| Title |
Persistent Difficulties in Switching to Second-Line ART in Sub-Saharan Africa — A Systematic Review and Meta-Analysis
|
|---|---|
| Published in |
PLOS ONE, December 2013
|
| DOI | 10.1371/journal.pone.0082724 |
| Pubmed ID | |
| Authors |
Yoann Madec, Sandrine Leroy, Marie-Anne Rey-Cuille, Florence Huber, Alexandra Calmy |
| Abstract |
Switching to second-line antiretroviral therapy (ART) largely depends on careful clinical assessment and access to biological measurements. We performed a systematic review and meta-analysis to estimate the incidence of switching to second-line ART in sub-Saharan Africa and its main programmatic determinants. |
X Demographics
The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 25% |
| South Africa | 1 | 25% |
| Unknown | 2 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 4 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 89 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Switzerland | 1 | 1% |
| Tanzania, United Republic of | 1 | 1% |
| Ethiopia | 1 | 1% |
| France | 1 | 1% |
| Kenya | 1 | 1% |
| Unknown | 84 | 94% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 22 | 25% |
| Researcher | 22 | 25% |
| Student > Ph. D. Student | 9 | 10% |
| Other | 5 | 6% |
| Student > Doctoral Student | 3 | 3% |
| Other | 11 | 12% |
| Unknown | 17 | 19% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 43 | 48% |
| Nursing and Health Professions | 5 | 6% |
| Immunology and Microbiology | 4 | 4% |
| Agricultural and Biological Sciences | 4 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 3 | 3% |
| Other | 9 | 10% |
| Unknown | 21 | 24% |